Inicio>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Methylisothiazolinone

Methylisothiazolinone (Synonyms: MI, MIT)

Catalog No.GC44183

La metilisotiazolinona es un biocida y conservante sintético que se puede utilizar ampliamente tanto en productos industriales como de consumo.

Products are for research use only. Not for human use. We do not sell to patients.

Methylisothiazolinone Chemical Structure

Cas No.: 2682-20-4

Tamaño Precio Disponibilidad Cantidad
1ml
43,00 $
Disponible
5ml
117,00 $
Disponible
10ml
214,00 $
Disponible
25ml
375,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Methylisothiazolinone (MI) is an isothiazolinone-derived biocide used for controlling microbial growth in industrial and household products, often in a mixture with 5-chloro-2-methyl-3-isothiazolone (MCI). MI is active against Gram-positive and Gram-negative bacteria, fungi, and yeast with MIC values of 0.0045, 0.0015, >0.01, and 0.0065% (w/w) for S. aureus, P. aeruginosa, A. niger, and C. albicans, respectively, when used alone. MIC values are 7 to 200-fold lower when MI is used in combination with MCI. MI decreases neurite outgrowth of rat cortical neurons when used at concentrations of 0.1-3 µM and inhibits Src family kinases in cell-free assays. MI, alone and as a mixture with MCI, can elicit contact sensitization.

Reseñas

Review for Methylisothiazolinone

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Methylisothiazolinone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.